Stefan Schillberg
Stefan Schillberg
Fraunhofer IME and RWTH Aachen University
Verified email at - Homepage
Cited by
Cited by
Molecular farming in plants: host systems and expression technology
RM Twyman, E Stoger, S Schillberg, P Christou, R Fischer
TRENDS in Biotechnology 21 (12), 570-578, 2003
Plant-based production of biopharmaceuticals
R Fischer, E Stoger, S Schillberg, P Christou, RM Twyman
Current opinion in plant biology 7 (2), 152-158, 2004
Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves
C Vaquero, M Sack, J Chandler, J Drossard, F Schuster, M Monecke, ...
Proceedings of the National Academy of Sciences 96 (20), 11128-11133, 1999
Molecular farming for new drugs and vaccines: current perspectives on the production of pharmaceuticals in transgenic plants
JKC Ma, E Barros, R Bock, P Christou, PJ Dale, PJ Dix, R Fischer, J Irwin, ...
EMBO reports 6 (7), 593-599, 2005
Critical analysis of the commercial potential of plants for the production of recombinant proteins
S Schillberg, N Raven, H Spiegel, S Rasche, M Buntru
Frontiers in Plant Science 10, 2019
GMP issues for recombinant plant-derived pharmaceutical proteins
R Fischer, S Schillberg, S Hellwig, RM Twyman, J Drossard
Biotechnology advances 30 (2), 434-439, 2012
Transgenic plants in the biopharmaceutical market
RM Twyman, S Schillberg, R Fischer
Expert opinion on emerging drugs 10 (1), 185-218, 2005
Molecular farming of recombinant antibodies in plants
S Schillberg, R Fischer, N Emans
Cellular and Molecular Life Sciences CMLS 60, 433-445, 2003
Opportunities for recombinant antigen and antibody expression in transgenic plants—technology assessment
S Schillberg, RM Twyman, R Fischer
Vaccine 23 (15), 1764-1769, 2005
Potential applications of plant biotechnology against SARS-CoV-2
T Capell, RM Twyman, V Armario-Najera, JKC Ma, S Schillberg, ...
Trends in plant science 25 (7), 635-643, 2020
Molecular farming of recombinant antibodies in plants
R Fischer, YC Liao, K Hoffmann, S Schillberg, N Emans
Walter de Gruyter 380 (7-8), 825-839, 1999
Apoplastic and cytosolic expression of full‐size antibodies and antibody fragments in Nicotiana tabacum
S Schillberg, S Zimmermann, A Voss, R Fischer
Transgenic research 8, 255-263, 1999
Intracellular expression of TMV-specific single-chain Fv fragments leads to improved virus resistance in shape Nicotiana tabacum
S Zimmermann, S Schillberg, YC Liao, R Fisher
Molecular Breeding 4, 369-379, 1998
Patterns of CRISPR/Cas9 activity in plants, animals and microbes
L Bortesi, C Zhu, J Zischewski, L Perez, L Bassiť, R Nadi, G Forni, ...
Plant Biotechnology Journal, 2016
Production of antibodies in plants and their use for global health
R Fischer, RM Twyman, S Schillberg
Vaccine 21 (7-8), 820-825, 2003
Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants
R Fischer, J Drossard, U Commandeur, S Schillberg, N Emans
Biotechnology and Applied Biochemistry 30 (2), 101-108, 1999
Characteristics of genome editing mutations in cereal crops
C Zhu, L Bortesi, C Baysal, RM Twyman, R Fischer, T Capell, S Schillberg, ...
Trends in Plant Science 22 (1), 38-52, 2017
Expression and characterization of bispecific single‐chain Fv fragments produced in transgenic plants
R Fischer, D Schumann, S Zimmermann, J Drossard, M Sack, ...
European Journal of Biochemistry 262 (3), 810-816, 1999
Commercial aspects of pharmaceutical protein production in plants
R Fischer, S Schillberg, J F Buyel, R M Twyman
Current pharmaceutical design 19 (31), 5471-5477, 2013
Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures
S Schillberg, N Raven, R Fischer, R M Twyman, A Schiermeyer
Current pharmaceutical design 19 (31), 5531-5542, 2013
The system can't perform the operation now. Try again later.
Articles 1–20